Skip to main content
. 2021 Aug 11;7(3):157–168. doi: 10.1016/j.cdtm.2021.07.001

Table 1.

Procedural characteristics and clinical outcomes of present series.

Characteristics PFCs (n = 12) PPC (n = 2) WON (n = 10)
Type of LAMS, n (%)
 DMHS 7 (58.3) 1 (50.0) 6 (60.0)
 AXIOS 5 (41.7) 1 (50.0) 4 (40.0)
Total No. of endoscopic reinterventions
 0 9 3 6
 1 1 0 1
 >1 2 0 2
Cyst irrigation, n (%) 1 (8.3) 0 1 (8.3)
Technical success, n (%)
 YES 12 (100) 2 (100) 10 (100)
Clinical success, n (%)
 YES 10 (83.3) 2 (100) 8 (80.0)
 NO 2 (16.7) 0 2 (20.0)
Adverse events, n (%)
 Infection 6 (50) 1 (50) 5 (50)
 Bleeding 0 0 0
 Stent migration 1 (8.3) 0 1 (10.0)
 Stent occlusion 1 (8.3) 0 1 (10.0)
Duration of procedure, min (mean ± SD) 65.6 ± 24.3 51.5 ± 23.3 68.4 ± 24.7
Hospital stay, days (mean ± SD) 17.1 ± 8.6 16.5 ± 3.5 17.2 ± 9.4
Days to stent removal, days (range) 29.6 (18–45) 27.5 (27–28]) 30.1 (18–45)

LAMS: lumen-apposing metal stents; PFCs: pancreatic fluid collections; PPC: pancreatic pseudocysts; WON: walled-off necrosis; SD: standard deviation.